<?xml version="1.0" encoding="UTF-8"?>
<p id="Par33">Of particularly note, some of the novel conserved epitopes are discontinuous (Stadlbauer 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR91">2019</xref>) or even occluded in their native state (Bajic 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR5">2019</xref>; Bangaru 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR6">2019</xref>; Watanabe 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR106">2019</xref>). How one can obtain and immunize against these epitopes remains a big issue. The advantage of synthetic epitope mimetics and de novo protein design may facilitate immunogens design for universal influenza vaccines in the future (Zerbe 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR119">2017</xref>; Grayson and Anderson 
 <xref ref-type="bibr" rid="CR37">2018</xref>).
</p>
